Newsfeeds - Spark Newswire

2 minute read

BrainStorm Cell Therapeutics Announces Promotion Of Dr. Stacy Lindborg To Co-Chief Executive Officer

Today, 2:00 PM

BrainStorm Cell Therapeutics Inc. (NASDAQ:BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced the promotion of Dr. Stacy Lindborg to the role of Co-Chief

BCLI

1 minute read

BrainStorm Cell Therapeutics Announces Type A Meeting With FDA Granted For NurOwn; Meeting Scheduled For Jan. 11, 2023

By Bill Haddad

Today, 2:00 PM

NEW YORK, Dec. 27, 2022 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ:BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced that the U.S.

BCLI

1 minute read

Movers

12 Health Care Stocks Moving In Friday’s After-Market Session

By Benzinga Insights

Today, 2:00 PM

Gainers Brainstorm Cell (NASDAQ:BCLI) stock moved upwards by 20.6% to $2.05 during Friday’s after-market session. The market value…

ANPC

8 minute read

Veterans With ALS Who Support Co’s Request For The FDA To Hold A Public Advisory Committee Meeting To Engage In Scientific Discourse About The “Clinically Meaningful” Evidence Supporting FDA’s Approval Of A Mesenchymal Stem Cell Therapy, NurOwn

By Benzinga Newsdesk

Today, 2:00 PM

Veterans have a Significantly Increased Risk of 100% Fatal ALS, Caused by their Service for our Country FDA Advisory Committee Meeting is Essential to Allow Veterans' Voices to be Heard about Need for

BCLI

5 minute read

Why American Eagle Outfitters Shares Climbed Over 18%; Here Are 78 Biggest Movers From Yesterday

By Lisa Levin

Today, 2:00 PM

Gainers Cosmos Holdings Inc. (NASDAQ: COSM) jumped 86.9% to close at $0.3275 on Tuesday after jumping 21% on Monday. Cosmos Health agreed to sell its Sky Premium Life Luxury food supplement brand on Iberian Airlines' in-flight magazine, Ronda.

17 minute read

Earnings

Earnings Scheduled For November 14, 2022

By Benzinga Insights

Today, 2:00 PM

Companies Reporting Before The Bell • Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million.

AAIC

3 minute read

Movers

12 Health Care Stocks Moving In Thursday’s Intraday Session

By Benzinga Insights

Today, 2:00 PM

Gainers

APYX

4 minute read

Why Magnite Shares Are Trading Higher By Over 45%? Here Are 69 Stocks Moving In Thursday’s Mid-Day Session

By Lisa Levin

Today, 2:00 PM

Gainers Fast Radius, Inc. (NASDAQ: FSRD) shares climbed 172% to $0.2769 after dipping 40% on Wednesday. Fast Radius received Bankruptcy court approval of first day motions related to the company's voluntary Chapter 11 petitions filed on November 7.

AAPL

5 minute read

BrainStorm Cell Therapeutics Presents New Analyses From NurOwn’s Phase 3 ALS Trial At The 21st Annual NEALS Meeting

By Benzinga Newsdesk

Today, 2:00 PM

BrainStorm Cell Therapeutics Inc. (NASDAQ:BCLI), a leading developer of cellular therapies for neurodegenerative diseases, today announced the presentation of a poster with new analyses from NurOwn's

BCLI

1 minute read

BrainStorm Cell Therapeutics Presents NurOwn Phase 2 Progressive MS Biomarker Data at the 38th ECTRIMS Congress

By Charles Gross

Today, 2:00 PM

BrainStorm Cell Therapeutics Inc.

BCLI